arrow
A

Allison L. Naleway

Kaiser Permanente Center for Health Research
H指数:61
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Meningococcal B Vaccination Patterns Across 10 Integrated Health Systems Within the Vaccine Safety Datalink, 2015-2023

脑膜炎球菌B疫苗接种模式:基于疫苗安全数据链的10个整合医疗系统,2015-2023

2026-08-010
PRE
Household Transmission of SARS-CoV-2 in Washington and Oregon, United States, 2022-2024

2022-2024年美国华盛顿州和俄勒冈州的家庭内SARS-CoV-2传播

2026-07-200
PRE
Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023-March 2024

相关性疫苗接种行为对老年人COVID-19疫苗有效性估计的影响——VISION网络,2023年10月至2024年3月

Vaccine
IF3.5
2026-07-010
PRE
Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naïve individuals associated with Omicron breakthrough infections

揭示与奥密克戎突破性感染相关的SARS-CoV-2感染-naïve个体疫苗接种后蛋白质组学特征

2026-05-110
OA
2023–2024 COVID-19 vaccination coverage in pregnancy in ten healthcare delivery organizations in the United States

2023–2024年美国十家医疗保健机构孕产妇COVID-19疫苗接种覆盖率

Vaccine
IF3.5
2026-03-120
OAAI
New Insights Into an Old Vaccine: Potency and Breadth of Neutralizing Antibodies Elicited by Yellow Fever Vaccine 17D Are Boosted by Heterologous Orthoflavivirus Infection

对一种老疫苗的新认识:黄热病疫苗17D诱导的中和抗体的效价和广度可被异源正黄病毒感染增强

2026-02-110
OAAI
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study

呼吸道合胞病毒疾病风险的关联因素:一项前瞻性队列研究

2025-09-260
OAAI
Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017–18 through 2022–23 influenza seasons

2017–18至2022–23流感季疫苗安全数据链中,不同年龄组按种族和族裔划分的流感疫苗接种覆盖率差异

Vaccine
IF3.5
2025-09-040
PRE
Parental intent to vaccinate children with the updated 2023–2024 COVID-19 vaccine

家长为孩子接种更新版2023–2024年COVID-19疫苗的意愿

Vaccine
IF3.5
2025-08-230
PRE
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023–March 2024: a test-negative design analysis

2023年10月至2024年3月美国首次RSV流行季中,尼瑞韦玛姆在婴儿中的有效性:一项测试阴性设计分析

2025-08-060
PRE
Effectiveness of 2023–2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age

2023–2024季节性流感疫苗对育龄期孕妇和非孕妇流感相关急诊和紧急护理就诊的有效性

Vaccine
IF3.5
2025-07-130
OA
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections

固有免疫原性是SARS-CoV-2感染中类型特异性反应的主要决定因素。

2025-05-270
PRE
Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023-2024
2025-04-010
PRE
Influenza-Associated Hospitalization Rates by Underlying Conditions, 2016-2017 to 2019-2020: A Retrospective Cohort Study

按基础疾病分组的流感相关住院率,2016-2017至2019-2020:一项回顾性队列研究

2025-03-280
PRE
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023
2025-03-010
PRE
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States

mRNA新型冠状病毒肺炎疫苗和杂交免疫预防美国成人SARS-CoV-2感染和症状新型冠状病毒肺炎的有效性

2025-01-080
PRE
Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023-2024 Season, United States
2024-12-041
PRE